Acumen Pharmaceuticals, Inc. (ABOS) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Acumen Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($166.4M and $161.6M). Acumen Pharmaceuticals, Inc. has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 16 metrics below, Tonix Pharmaceuticals Holding Corp. leads on 9 and Acumen Pharmaceuticals, Inc. on 7.

Valuation

Metric ABOS TNXP Biotechnology median
P/E n/m n/m 7.88
P/S 112.70 5.64 11.47
P/B 2.83 0.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.03 0.74
EV/Sales 57.95 (0.16) 10.73
Earnings yield (72.77%) (134.34%) (28.84%)
Free cash flow yield (56.77%) (96.39%) (23.03%)

Profitability

Metric ABOS TNXP Biotechnology median
Gross margin 0.00% 83.83% 65.16%
Operating margin 0.00% (568.43%) 0.00%
Net margin 0.00% (548.64%) 0.00%
Free cash flow margin 0.00% (543.29%) 0.00%
Return on equity (120.50%) (81.82%) (57.72%)
Return on assets (72.97%) (72.34%) (49.22%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric ABOS TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 5.64%
EPS growth (last fiscal year) (16.96%) 91.75% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABOS TNXP Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 2.47 6.61 4.73
Net debt to EBITDA 0.69 1.68 0.96

Dividend

Metric ABOS TNXP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABOS TNXP Biotechnology median
Market cap 161.63m 166.36m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack